PLA2G2A and COVID-19: Most recently, an independent cohort study has demonstrated elevated levels of GIIA sPLA2 in the plasma of deceased patients in comparison to patients with severe or mild COVID-19, indicating that GIIA sPLA2 is associated with increased mortality due to COVID-19 [12].